The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti-Inflammatory Cytokine Market Research Report 2022

Global Anti-Inflammatory Cytokine Market Research Report 2022

Publishing Date : May, 2022

License Type :
 

Report Code : 1696755

No of Pages : 92

Synopsis

Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. 

Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Inflammatory Cytokine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Inflammatory Cytokine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cardiovascular Diseases segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Anti-Inflammatory Cytokine include Merck KGaA, Eli Lilly and Company, Pfizer Inc., Sanofi S.A., Novartis AG, Hoffmann-La Roche Ltd., Lonza Group Ltd., Thermo Fisher Scientific and Meridian Bioscience Inc., etc. In terms of revenue, the global 3 largest players have a % market share of Anti-Inflammatory Cytokine in 2021.
This report focuses on Anti-Inflammatory Cytokine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Inflammatory Cytokine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Anti-Inflammatory Cytokine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Oral
  • Intravenous
  • Others

Segment by Application

  • Cardiovascular Diseases
  • Osteoarthritis
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Merck KGaA
  • Eli Lilly and Company
  • Pfizer Inc.
  • Sanofi S.A.
  • Novartis AG
  • Hoffmann-La Roche Ltd.
  • Lonza Group Ltd.
  • Thermo Fisher Scientific
  • Meridian Bioscience Inc.
  • General Electric Company
  • Abcam PLC
  • GenScript Biotech Corp
  • Applied Biological Materials Inc.
  • Randox Laboratories
Index

1 Anti-Inflammatory Cytokine Market Overview
1.1 Product Overview and Scope of Anti-Inflammatory Cytokine
1.2 Anti-Inflammatory Cytokine Segment by Type
1.2.1 Global Anti-Inflammatory Cytokine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Anti-Inflammatory Cytokine Segment by Application
1.3.1 Global Anti-Inflammatory Cytokine Sales Comparison by Application: (2022-2028)
1.3.2 Cardiovascular Diseases
1.3.3 Osteoarthritis
1.3.4 Others
1.4 Global Anti-Inflammatory Cytokine Market Size Estimates and Forecasts
1.4.1 Global Anti-Inflammatory Cytokine Revenue 2017-2028
1.4.2 Global Anti-Inflammatory Cytokine Sales 2017-2028
1.4.3 Anti-Inflammatory Cytokine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-Inflammatory Cytokine Market Competition by Manufacturers
2.1 Global Anti-Inflammatory Cytokine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-Inflammatory Cytokine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-Inflammatory Cytokine Manufacturing Sites, Area Served, Product Type
2.5 Anti-Inflammatory Cytokine Market Competitive Situation and Trends
2.5.1 Anti-Inflammatory Cytokine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Inflammatory Cytokine Players Market Share by Revenue
2.5.3 Global Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Inflammatory Cytokine Retrospective Market Scenario by Region
3.1 Global Anti-Inflammatory Cytokine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-Inflammatory Cytokine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.3.1 North America Anti-Inflammatory Cytokine Sales by Country
3.3.2 North America Anti-Inflammatory Cytokine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.4.1 Europe Anti-Inflammatory Cytokine Sales by Country
3.4.2 Europe Anti-Inflammatory Cytokine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Inflammatory Cytokine Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Inflammatory Cytokine Sales by Region
3.5.2 Asia Pacific Anti-Inflammatory Cytokine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.6.1 Latin America Anti-Inflammatory Cytokine Sales by Country
3.6.2 Latin America Anti-Inflammatory Cytokine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Inflammatory Cytokine Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Inflammatory Cytokine Sales by Country
3.7.2 Middle East and Africa Anti-Inflammatory Cytokine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Inflammatory Cytokine Historic Market Analysis by Type
4.1 Global Anti-Inflammatory Cytokine Sales Market Share by Type (2017-2022)
4.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Type (2017-2022)
4.3 Global Anti-Inflammatory Cytokine Price by Type (2017-2022)
5 Global Anti-Inflammatory Cytokine Historic Market Analysis by Application
5.1 Global Anti-Inflammatory Cytokine Sales Market Share by Application (2017-2022)
5.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Application (2017-2022)
5.3 Global Anti-Inflammatory Cytokine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Corporation Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck KGaA Anti-Inflammatory Cytokine Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Sanofi S.A.
6.4.1 Sanofi S.A. Corporation Information
6.4.2 Sanofi S.A. Description and Business Overview
6.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Product Portfolio
6.4.5 Sanofi S.A. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novartis AG Anti-Inflammatory Cytokine Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Hoffmann-La Roche Ltd.
6.6.1 Hoffmann-La Roche Ltd. Corporation Information
6.6.2 Hoffmann-La Roche Ltd. Description and Business Overview
6.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product Portfolio
6.6.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
6.7 Lonza Group Ltd.
6.6.1 Lonza Group Ltd. Corporation Information
6.6.2 Lonza Group Ltd. Description and Business Overview
6.6.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Product Portfolio
6.7.5 Lonza Group Ltd. Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Meridian Bioscience Inc.
6.9.1 Meridian Bioscience Inc. Corporation Information
6.9.2 Meridian Bioscience Inc. Description and Business Overview
6.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product Portfolio
6.9.5 Meridian Bioscience Inc. Recent Developments/Updates
6.10 General Electric Company
6.10.1 General Electric Company Corporation Information
6.10.2 General Electric Company Description and Business Overview
6.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 General Electric Company Anti-Inflammatory Cytokine Product Portfolio
6.10.5 General Electric Company Recent Developments/Updates
6.11 Abcam PLC
6.11.1 Abcam PLC Corporation Information
6.11.2 Abcam PLC Anti-Inflammatory Cytokine Description and Business Overview
6.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Abcam PLC Anti-Inflammatory Cytokine Product Portfolio
6.11.5 Abcam PLC Recent Developments/Updates
6.12 GenScript Biotech Corp
6.12.1 GenScript Biotech Corp Corporation Information
6.12.2 GenScript Biotech Corp Anti-Inflammatory Cytokine Description and Business Overview
6.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 GenScript Biotech Corp Anti-Inflammatory Cytokine Product Portfolio
6.12.5 GenScript Biotech Corp Recent Developments/Updates
6.13 Applied Biological Materials Inc.
6.13.1 Applied Biological Materials Inc. Corporation Information
6.13.2 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Description and Business Overview
6.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product Portfolio
6.13.5 Applied Biological Materials Inc. Recent Developments/Updates
6.14 Randox Laboratories
6.14.1 Randox Laboratories Corporation Information
6.14.2 Randox Laboratories Anti-Inflammatory Cytokine Description and Business Overview
6.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Randox Laboratories Anti-Inflammatory Cytokine Product Portfolio
6.14.5 Randox Laboratories Recent Developments/Updates
7 Anti-Inflammatory Cytokine Manufacturing Cost Analysis
7.1 Anti-Inflammatory Cytokine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Inflammatory Cytokine
7.4 Anti-Inflammatory Cytokine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Inflammatory Cytokine Distributors List
8.3 Anti-Inflammatory Cytokine Customers
9 Anti-Inflammatory Cytokine Market Dynamics
9.1 Anti-Inflammatory Cytokine Industry Trends
9.2 Anti-Inflammatory Cytokine Market Drivers
9.3 Anti-Inflammatory Cytokine Market Challenges
9.4 Anti-Inflammatory Cytokine Market Restraints
10 Global Market Forecast
10.1 Anti-Inflammatory Cytokine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Type (2023-2028)
10.2 Anti-Inflammatory Cytokine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Application (2023-2028)
10.3 Anti-Inflammatory Cytokine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti-Inflammatory Cytokine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Anti-Inflammatory Cytokine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Anti-Inflammatory Cytokine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Anti-Inflammatory Cytokine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Anti-Inflammatory Cytokine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Anti-Inflammatory Cytokine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Anti-Inflammatory Cytokine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Anti-Inflammatory Cytokine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Anti-Inflammatory Cytokine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Anti-Inflammatory Cytokine Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Inflammatory Cytokine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Inflammatory Cytokine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Inflammatory Cytokine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Inflammatory Cytokine Sales by Region (2017-2022) & (K Units)
Table 16. Global Anti-Inflammatory Cytokine Sales Market Share by Region (2017-2022)
Table 17. Global Anti-Inflammatory Cytokine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Anti-Inflammatory Cytokine Revenue Market Share by Region (2017-2022)
Table 19. North America Anti-Inflammatory Cytokine Sales by Country (2017-2022) & (K Units)
Table 20. North America Anti-Inflammatory Cytokine Sales Market Share by Country (2017-2022)
Table 21. North America Anti-Inflammatory Cytokine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Anti-Inflammatory Cytokine Revenue Market Share by Country (2017-2022)
Table 23. Europe Anti-Inflammatory Cytokine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Anti-Inflammatory Cytokine Sales Market Share by Country (2017-2022)
Table 25. Europe Anti-Inflammatory Cytokine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Anti-Inflammatory Cytokine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Anti-Inflammatory Cytokine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Anti-Inflammatory Cytokine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Anti-Inflammatory Cytokine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Anti-Inflammatory Cytokine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Anti-Inflammatory Cytokine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Anti-Inflammatory Cytokine Sales Market Share by Country (2017-2022)
Table 33. Latin America Anti-Inflammatory Cytokine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Anti-Inflammatory Cytokine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Anti-Inflammatory Cytokine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Anti-Inflammatory Cytokine Revenue Market Share by Country (2017-2022)
Table 39. Global Anti-Inflammatory Cytokine Sales by Type (2017-2022) & (K Units)
Table 40. Global Anti-Inflammatory Cytokine Sales Market Share by Type (2017-2022)
Table 41. Global Anti-Inflammatory Cytokine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Anti-Inflammatory Cytokine Revenue Share by Type (2017-2022)
Table 43. Global Anti-Inflammatory Cytokine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Anti-Inflammatory Cytokine Sales (K Units) by Application (2017-2022)
Table 45. Global Anti-Inflammatory Cytokine Sales Market Share by Application (2017-2022)
Table 46. Global Anti-Inflammatory Cytokine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Anti-Inflammatory Cytokine Revenue Share by Application (2017-2022)
Table 48. Global Anti-Inflammatory Cytokine Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck KGaA Corporation Information
Table 50. Merck KGaA Description and Business Overview
Table 51. Merck KGaA Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck KGaA Anti-Inflammatory Cytokine Product
Table 53. Merck KGaA Recent Developments/Updates
Table 54. Eli Lilly and Company Corporation Information
Table 55. Eli Lilly and Company Description and Business Overview
Table 56. Eli Lilly and Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Eli Lilly and Company Anti-Inflammatory Cytokine Product
Table 58. Eli Lilly and Company Recent Developments/Updates
Table 59. Pfizer Inc. Corporation Information
Table 60. Pfizer Inc. Description and Business Overview
Table 61. Pfizer Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Inc. Anti-Inflammatory Cytokine Product
Table 63. Pfizer Inc. Recent Developments/Updates
Table 64. Sanofi S.A. Corporation Information
Table 65. Sanofi S.A. Description and Business Overview
Table 66. Sanofi S.A. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi S.A. Anti-Inflammatory Cytokine Product
Table 68. Sanofi S.A. Recent Developments/Updates
Table 69. Novartis AG Corporation Information
Table 70. Novartis AG Description and Business Overview
Table 71. Novartis AG Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Novartis AG Anti-Inflammatory Cytokine Product
Table 73. Novartis AG Recent Developments/Updates
Table 74. Hoffmann-La Roche Ltd. Corporation Information
Table 75. Hoffmann-La Roche Ltd. Description and Business Overview
Table 76. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product
Table 78. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 79. Lonza Group Ltd. Corporation Information
Table 80. Lonza Group Ltd. Description and Business Overview
Table 81. Lonza Group Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Lonza Group Ltd. Anti-Inflammatory Cytokine Product
Table 83. Lonza Group Ltd. Recent Developments/Updates
Table 84. Thermo Fisher Scientific Corporation Information
Table 85. Thermo Fisher Scientific Description and Business Overview
Table 86. Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Thermo Fisher Scientific Anti-Inflammatory Cytokine Product
Table 88. Thermo Fisher Scientific Recent Developments/Updates
Table 89. Meridian Bioscience Inc. Corporation Information
Table 90. Meridian Bioscience Inc. Description and Business Overview
Table 91. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product
Table 93. Meridian Bioscience Inc. Recent Developments/Updates
Table 94. General Electric Company Corporation Information
Table 95. General Electric Company Description and Business Overview
Table 96. General Electric Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. General Electric Company Anti-Inflammatory Cytokine Product
Table 98. General Electric Company Recent Developments/Updates
Table 99. Abcam PLC Corporation Information
Table 100. Abcam PLC Description and Business Overview
Table 101. Abcam PLC Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Abcam PLC Anti-Inflammatory Cytokine Product
Table 103. Abcam PLC Recent Developments/Updates
Table 104. GenScript Biotech Corp Corporation Information
Table 105. GenScript Biotech Corp Description and Business Overview
Table 106. GenScript Biotech Corp Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. GenScript Biotech Corp Anti-Inflammatory Cytokine Product
Table 108. GenScript Biotech Corp Recent Developments/Updates
Table 109. Applied Biological Materials Inc. Corporation Information
Table 110. Applied Biological Materials Inc. Description and Business Overview
Table 111. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product
Table 113. Applied Biological Materials Inc. Recent Developments/Updates
Table 114. Randox Laboratories Corporation Information
Table 115. Randox Laboratories Description and Business Overview
Table 116. Randox Laboratories Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Randox Laboratories Anti-Inflammatory Cytokine Product
Table 118. Randox Laboratories Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Anti-Inflammatory Cytokine Distributors List
Table 122. Anti-Inflammatory Cytokine Customers List
Table 123. Anti-Inflammatory Cytokine Market Trends
Table 124. Anti-Inflammatory Cytokine Market Drivers
Table 125. Anti-Inflammatory Cytokine Market Challenges
Table 126. Anti-Inflammatory Cytokine Market Restraints
Table 127. Global Anti-Inflammatory Cytokine Sales Forecast by Type (2023-2028) & (K Units)
Table 128. Global Anti-Inflammatory Cytokine Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Anti-Inflammatory Cytokine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Anti-Inflammatory Cytokine Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Anti-Inflammatory Cytokine Sales Forecast by Application (2023-2028) & (K Units)
Table 132. Global Anti-Inflammatory Cytokine Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Anti-Inflammatory Cytokine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Anti-Inflammatory Cytokine Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Anti-Inflammatory Cytokine Sales Forecast by Region (2023-2028) & (K Units)
Table 136. Global Anti-Inflammatory Cytokine Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Anti-Inflammatory Cytokine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Anti-Inflammatory Cytokine Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Inflammatory Cytokine
Figure 2. Global Anti-Inflammatory Cytokine Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Intravenous Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Inflammatory Cytokine Market Share by Application in 2021 & 2028
Figure 7. Cardiovascular Diseases
Figure 8. Osteoarthritis
Figure 9. Others
Figure 10. Global Anti-Inflammatory Cytokine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Anti-Inflammatory Cytokine Market Size (2017-2028) & (US$ Million)
Figure 12. Global Anti-Inflammatory Cytokine Sales (2017-2028) & (K Units)
Figure 13. Anti-Inflammatory Cytokine Sales Share by Manufacturers in 2021
Figure 14. Global Anti-Inflammatory Cytokine Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Anti-Inflammatory Cytokine Players: Market Share by Revenue in 2021
Figure 16. Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Anti-Inflammatory Cytokine Sales Market Share by Region (2017-2022)
Figure 18. Global Anti-Inflammatory Cytokine Sales Market Share by Region in 2021
Figure 19. Global Anti-Inflammatory Cytokine Revenue Market Share by Region (2017-2022)
Figure 20. Global Anti-Inflammatory Cytokine Revenue Market Share by Region in 2021
Figure 21. United States Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Anti-Inflammatory Cytokine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Anti-Inflammatory Cytokine by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Anti-Inflammatory Cytokine
Figure 45. Manufacturing Process Analysis of Anti-Inflammatory Cytokine
Figure 46. Anti-Inflammatory Cytokine Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’